Transgenic plants as protein factories

Current Opinion in Biotechnology

Volumn 12, Issue 5, 2001, Pages 450-454

  Giddings, Glynis ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; ANTIBODY; CARORX; GLUCOSYLCERAMIDASE; GLYCAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE; NORWALK VIRUS CAPSID PROTEIN; PROTEIN; RECOMBINANT ANTIBODY; RECOMBINANT ENTEROTOXIN; UNCLASSIFIED DRUG; VACCINE;

BIOTECHNOLOGY; DRUG MANUFACTURE; GLYCOSYLATION; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; TRANSGENIC PLANT;

MIRIDAE; NORWALK VIRUS;

EID: 0035477961     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00244-5     Document Type: Review

References (50)

1. Foreign protein production in plant tissue cultures
2. Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies
3. Cowpea mosaic virus as a vaccine carrier of heterologous antigens
4. Transgenic plants as factories for biopharmaceuticals
5. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection
6. Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P.aeruginosa
7. Process and economic evaluation of the extraction and purification of recombinant glucouronidase from transgenic corn
8. Production of enzymes for industrial use
9. Plants as factories for technical materials
10. Molecular farming of pharmaceutical proteins
11. Production of recombinant proteins in transgenic plants: Practical considerations
12. Antibody production by molecular farming in plants
13. Production of monoclonal antibody in perennial alfalfa plants
14. Molecular farming of industrial proteins from transgenic maize
15. Commercial production of Avidin from transgenic maize: Characterization of transformant, production, processing, extraction, and purification
16. Sorting of glycoprotein B from human cytomegalovirus to protein storage vesicles in seeds of transgenic tobacco
17. Effect of processing on the recovery of recombinant β-glucouronidase (rGUS) from transgenic canola
18. Production of biologically active hirudin in plant seeds using oleosin partitioning
19. Genes, greens and vaccines
20. Edible vaccines
21. Plants for delivery of edible vaccines
22. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
23. Efficacy of a food plant-based oral cholera toxin B subunit vaccine
24. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
25. Production of hepatitis B surface antigen in transgenic plants for oral immunization
26. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1
27. High-yield production of a human therapeutic protein in tobacco chloroplasts
28. Antigen processing and presentation by intestinal epithelial cells - Polarity and complexity
29. Transgenic pea seeds as bioreactors for the production of a single-chain Fv fragment (scFV) antibody used in cancer diagnosis and therapy
30. Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies
31. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans
32. Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants
33. Assembly of an antibody and its derived antibody fragment in Nicotiana and Arabidopsis
34. Transient expression of a tumour specific single chain fragment and chimeric antibody in tobacco leaves
35. Bioproduction of human enzymes in transgenic tobacco
36. Establishment of a transgenic tobacco cell suspension culture system for producing murine granulocyte-macrophage colony stimulating factor
37. Expression of correctly processed human growth hormone in seeds of transgenic tobacco plants
38. Expression of murine adenosine deaminase (ADA) in transgenic maize
39. N-glycosylation of a mouse IgG expressed in transgenic tobacco plants
40. A murine monoclonal antibody produced in transgenic plants with plant-specific glycans is not immunogenic in mice
41. Accumulation of a thermostable endo-1,4-β-d-glucanase in the apoplast of Arabidopsis thaliana leaves
42. Stable accumulation of Aspergillus niger phytase in transgenic tobacco leaves
43. Production of new/modified proteins in transgenic plants
44. Comparison of phytase from genetically engineered Aspergillus and canola in weanling pig diets
45. Expression of full-length bioactive antimicrobial human lactoferrin in potato plants
46. Expression of human milk protein β-casein in transgenic potato plants
47. Production of new polymeric compounds in plants
48. Stable expression of a biodegradable protein-based polymer in stable tobacco chloroplasts
49. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants
50. Production of recombinant collagen for biomedical devices